Zobrazeno 1 - 10
of 27
pro vyhledávání: '"Sidsel Arnspang Pedersen"'
Autor:
Julie Krumborg, Nicolaj Mikkelsen, Per Damkier, Zandra Ennis, Daniel Pilsgaard Henriksen, Mads Lillevang-Johansen, Sidsel Arnspang Pedersen, Troels Bergmann
Publikováno v:
Basic & Clinical Pharmacology & Toxicology.
Background: Serotonin syndrome is a potentially life-threatening syndrome with manifestations spanning from mild adverse effects to life-threatening toxicity. The syndrome is caused by overstimulation of serotonin receptors by serotonergic drugs. Sin
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::35afb8368229aec052f6fb1b3f5c6e79
https://doi.org/10.22541/au.167905813.34118618/v1
https://doi.org/10.22541/au.167905813.34118618/v1
Autor:
Charlotte Andersen, Sidsel Arnspang Pedersen, Kim Dalhoff, Mette Findal Andreasen, Tilo Klesse
Publikováno v:
Pedersen, S A, Klesse, T, Findal Andreasen, M, Dalhoff, K P & Andersen, C U 2020, ' Active chlordiazepoxide metabolites in a patient needing life support after treatment of alcohol abstinence ', Basic and Clinical Pharmacology and Toxicology, vol. 127, no. 5, pp. 438-441 . https://doi.org/10.1111/bcpt.13449
Pedersen, S A, Klesse, T, Findal Andreasen, M, Dalhoff, K P & Andersen, C U 2020, ' Active chlordiazepoxide metabolites in a patient needing life support after treatment of alcohol abstinence ', Basic & Clinical Pharmacology & Toxicology, vol. 127, no. 5, pp. 438-441 . https://doi.org/10.1111/bcpt.13449
Pedersen, S A, Klesse, T, Andreasen, M F, Dalhoff, K P & Andersen, C U 2020, ' Active chlordiazepoxide metabolites in a patient needing life support after treatment of alcohol abstinence ', Basic & Clinical Pharmacology & Toxicology, vol. 127, no. 5, pp. 438-441 . https://doi.org/10.1111/bcpt.13449
Pedersen, S A, Klesse, T, Findal Andreasen, M, Dalhoff, K P & Andersen, C U 2020, ' Active chlordiazepoxide metabolites in a patient needing life support after treatment of alcohol abstinence ', Basic & Clinical Pharmacology & Toxicology, vol. 127, no. 5, pp. 438-441 . https://doi.org/10.1111/bcpt.13449
Pedersen, S A, Klesse, T, Andreasen, M F, Dalhoff, K P & Andersen, C U 2020, ' Active chlordiazepoxide metabolites in a patient needing life support after treatment of alcohol abstinence ', Basic & Clinical Pharmacology & Toxicology, vol. 127, no. 5, pp. 438-441 . https://doi.org/10.1111/bcpt.13449
Autor:
Lauren Angnardo, David Gaist, Sidsel Arnspang Pedersen, Christopher M. Wolfe, Armand B. Cognetta, Sae Han, Anton Pottegård
Publikováno v:
Han, S, Wolfe, C M, Angnardo, L, Pedersen, S A, Gaist, D, Pottegård, A & Cognetta, A B 2020, ' Hydrochlorothiazide Use and Increased Squamous Cell Carcinoma Burden in a High-Risk Mohs Population : A Cross-Sectional Study ', Dermatologic Surgery, vol. 46, no. 5, pp. 704-708 . https://doi.org/10.1097/DSS.0000000000001875
Autor:
Anton Pottegård, Kasper Bruun Kristensen, Sidsel Arnspang Pedersen, Sigrún Alba Jóhannesdóttir Schmidt
Publikováno v:
Kristensen, K B, Pedersen, S A, Schmidt, S A J & Pottegård, A 2020, ' Use of antiepileptic drugs and risk of skin cancer : A nationwide case-control study ', Journal of the American Academy of Dermatology, vol. 82, no. 2, pp. 326-335 . https://doi.org/10.1016/j.jaad.2019.05.055
Background: Several antiepileptic drugs are photosensitizing; however, it is not known whether this confers an increased risk of skin cancer. Objective: To examine the association between common antiepileptic drugs and basal cell carcinoma, squamous
Publikováno v:
Pottegård, A, Bech, B H, Pedersen, S A & Christensen, B 2021, ' Use of hydrochlorothiazide in Denmark following publication of skin cancer risk findings ', Pharmacoepidemiology and Drug Safety, vol. 30, no. 11, pp. 1611-1616 . https://doi.org/10.1002/pds.5350
University of Southern Denmark
Pottegard, A, Bech, B H, Pedersen, S A & Christensen, B 2020, ' Use of hydrochlorothiazide in Denmark following publication of skin cancer risk findings ', Pharmacoepidemiology and Drug Safety, vol. 29, no. Suppl. 3, 90, pp. 141 .
University of Southern Denmark
Pottegard, A, Bech, B H, Pedersen, S A & Christensen, B 2020, ' Use of hydrochlorothiazide in Denmark following publication of skin cancer risk findings ', Pharmacoepidemiology and Drug Safety, vol. 29, no. Suppl. 3, 90, pp. 141 .
Purpose: The antihypertensive agent hydrochlorothiazide has recently been linked to increased risk of skin cancer. We sought to describe the impact of the dissemination of these findings on the use of hydrochlorothiazide and health care utilization a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0f7ce6ce1b02cb7f55382fa947432bf2
https://portal.findresearcher.sdu.dk/da/publications/ad299d61-28d4-4ee9-994e-d588101cb09f
https://portal.findresearcher.sdu.dk/da/publications/ad299d61-28d4-4ee9-994e-d588101cb09f
Publikováno v:
Pedersen, S A & Pottegård, A 2021, ' Reply to “Comment on ‘Hydrochlorothiazide use and risk of nonmelanoma skin cancer : a nationwide case-control study from Denmark' " ', Journal of the American Academy of Dermatology, vol. 85, no. 6, pp. e359-e360 . https://doi.org/10.1016/j.jaad.2019.02.019
Autor:
Kim Brøsen, Tore Bjerregaard Stage, Mette Marie Hougaard Christensen, Sidsel Arnspang Pedersen, Peter Skov Esbech, Ida Kuhlmann
Publikováno v:
Kuhlmann, I, Arnspang Pedersen, S, Skov Esbech, P, Bjerregaard Stage, T, Hougaard Christensen, M M & Brøsen, K 2021, ' Using a limited sampling strategy to investigate the interindividual pharmacokinetic variability in metformin : A large prospective trial ', British Journal of Clinical Pharmacology, vol. 87, no. 4, pp. 1963-1969 . https://doi.org/10.1111/bcp.14591
Aims: Recently a limited sampling strategy (LSS) for determination of metformin' pharmacokinetics was developed. The LSS utilizes the plasma concentration of metformin 3 and 10 hours after oral intake of a single dose to estimate the area under the c
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::646972af0eb41422f766cef9a159e6a0
https://findresearcher.sdu.dk:8443/ws/files/174894174/bcp.14591.pdf
https://findresearcher.sdu.dk:8443/ws/files/174894174/bcp.14591.pdf
Publikováno v:
Pottegård, A, Pedersen, S A, Cognetta, A & Kristensen, K B 2020, ' No association between hydrochlorothiazide use and uveal melanoma ', European Journal of clinical pharmacology, vol. 76, pp. 1343-1344 . https://doi.org/10.1007/s00228-020-02908-x
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d4f8d63cd7ec029bb1c0dace3a786611
https://findresearcher.sdu.dk:8443/ws/files/170851025/HCTZ_uveal_Manuscript.pdf
https://findresearcher.sdu.dk:8443/ws/files/170851025/HCTZ_uveal_Manuscript.pdf
Autor:
Kasper Bruun Kristensen, Anton Pottegård, Blánaid Hicks, Lisbet Rosenkrantz Hölmich, Sidsel Arnspang Pedersen
Publikováno v:
Hicks, B, Bruun Kristensen, K, Arnspang Pedersen, S, Rosenkrantz Hölmich, L & Pottegård, A 2019, ' Hormone replacement therapy and the risk of melanoma in post-menopausal women ', Human reproduction . https://doi.org/10.1093/humrep/dez222
Hicks, B M, Kristensen, K B, Pedersen, S A, Hölmich, L R & Pottegård, A 2019, ' Hormone replacement therapy and the risk of melanoma in post-menopausal women ', Human reproduction (Oxford, England), vol. 34, no. 12, pp. 2418-2429 . https://doi.org/10.1093/humrep/dez222
University of Southern Denmark
Hicks, B, Kristensen, K B, Pedersen, S A, Holmich, L R & Pottegard, A 2019, ' Hormone replacement therapy and the risk of melanoma in post-menopausal women ', Pharmacoepidemiology and Drug Safety, vol. 28, no. 2, SI, pp. 441-442 . < https://doi.org/10.1002/pds.4864 >
Hicks, B M, Kristensen, K B, Pedersen, S A, Hölmich, L R & Pottegård, A 2019, ' Hormone replacement therapy and the risk of melanoma in post-menopausal women ', Human Reproduction, vol. 34, no. 12, pp. 2418-2429 . https://doi.org/10.1093/humrep/dez222
Hicks, B M, Kristensen, K B, Pedersen, S A, Hölmich, L R & Pottegård, A 2019, ' Hormone replacement therapy and the risk of melanoma in post-menopausal women ', Human reproduction (Oxford, England), vol. 34, no. 12, pp. 2418-2429 . https://doi.org/10.1093/humrep/dez222
University of Southern Denmark
Hicks, B, Kristensen, K B, Pedersen, S A, Holmich, L R & Pottegard, A 2019, ' Hormone replacement therapy and the risk of melanoma in post-menopausal women ', Pharmacoepidemiology and Drug Safety, vol. 28, no. 2, SI, pp. 441-442 . < https://doi.org/10.1002/pds.4864 >
Hicks, B M, Kristensen, K B, Pedersen, S A, Hölmich, L R & Pottegård, A 2019, ' Hormone replacement therapy and the risk of melanoma in post-menopausal women ', Human Reproduction, vol. 34, no. 12, pp. 2418-2429 . https://doi.org/10.1093/humrep/dez222
Study Question Is hormone replacement therapy (HRT) associated with an increased risk of melanoma skin cancer or prognostic outcomes amongst post-menopausal women? SUMMARY ANSWER Whilst we found evidence of an association with melanoma risk, the lack
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::00f8081b9cce87d36532b81d3e64dba0
https://pure.qub.ac.uk/en/publications/hormone-replacement-therapy-and-the-risk-of-melanoma-in-postmenopausal-women(85e0e910-bc37-41f8-aee1-d19f2941fab7).html
https://pure.qub.ac.uk/en/publications/hormone-replacement-therapy-and-the-risk-of-melanoma-in-postmenopausal-women(85e0e910-bc37-41f8-aee1-d19f2941fab7).html